Biomarin Pharmaceutical Inc. lobbies on its own behalf. For Q3 2026 it reported $200K across 1 client report and lists 3 lobbyists across its filings. Issues include Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | $200K | Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.07M | 1 |
| 2025 | $1.32M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.